NCT06638632 · NOT YET RECRUITING

Decision Aid for Dementia Therapies

This study is building a decision aid, a tool that helps people with early memory problems and their families think through medication choices for dementia. It is not testing a drug. It is a behavioral study with no phase, since nothing is being tested for safety or effectiveness. Details are limited so far.

Eligibility criteria

Inclusion Criteria:
Patients:
* UCHealth patient
* Ages 18 y/o and above
* Documented neurocognitive deficits suggestive of mild cognitive impairment or early dementia as determined by their treating clinician.
* English or Spanish speaking
Caregiver:
* Ages 18 y/o and above
* Identified by the study participant as the person who helps the most with their medical care outside the hospital or clinic.
* English or Spanish speaking
Clinicians:
* Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making.
* English or Spanish speaking
Exclusion Criteria:
Patients:
* Not English or Spanish-speaking
* Neurocognitive deficits suggestive of moderate or severe cognitive impairment or late stage dementia.
* Not able to consent for themselves
Caregiver:
* Ages 17 y/o and below
* Not English or Spanish-speaking
Clinicians:
* Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making.
* English or Spanish-speaking

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-09-16

View full record on ClinicalTrials.gov

All APOE4 clinical trials